Hay, Joel W.; Yu, Winnie M.; Ashraf, Talat - In: PharmacoEconomics 15 (1999) 1, pp. 47-74
Cardiovascular disease is the leading cause of death and the leading source of healthcare expenditure in the US and most other industrialised countries. Cholesterol lowering by pharmacological means prevents atherosclerotic plaque progression and has been shown to reduce both fatal and nonfatal...